These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 18372257

  • 1. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I, LARC Guideline Development Group.
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Achieving cost-neutrality with long-acting reversible contraceptive methods.
    Trussell J, Hassan F, Lowin J, Law A, Filonenko A.
    Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D, Spector H, Monteith C, Chen PL, Hart C.
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.
    Trussell J, Hassan F, Henry N, Pocoski J, Law A, Filonenko A.
    Contraception; 2014 May; 89(5):451-9. PubMed ID: 24576791
    [Abstract] [Full Text] [Related]

  • 12. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W, Bahamondes MV, Bahamondes L.
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [Abstract] [Full Text] [Related]

  • 13. Long-acting reversible contraception: a review in special populations.
    Prescott GM, Matthews CM.
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [Abstract] [Full Text] [Related]

  • 14. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
    Moray KV, Chaurasia H, Sachin O, Joshi B.
    Reprod Health; 2021 Jan 06; 18(1):4. PubMed ID: 33407632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M, Torres L, Vollett-Krech J, Wohltjen H.
    Clin Obstet Gynecol; 2014 Dec 06; 57(4):718-30. PubMed ID: 25314089
    [Abstract] [Full Text] [Related]

  • 17. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J, Jurich J, Fuchs R.
    Contraception; 2016 Mar 06; 93(3):266-72. PubMed ID: 26577755
    [Abstract] [Full Text] [Related]

  • 18. Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.
    Rademacher KH, Solomon M, Brett T, Bratt JH, Pascual C, Njunguru J, Steiner MJ.
    Glob Health Sci Pract; 2016 Aug 11; 4 Suppl 2(Suppl 2):S83-93. PubMed ID: 27540128
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.